Key facts
- It has raised $11.5M.
- Notable investors include US National Science Foundation, Climate Capital, E14 Fund, The Engine, Activate Global — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Robigo
- ·The full record, as it builds
Funding rounds
No funding rounds for Robigo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Robigo
Developer of precision microbial treatments designed to improve plant health and recover lost yields. The company's technology leverages microbial engineering and data science to create products that are more productive and safe for other beneficial microbes, pollinators, humans and the environment, enabling farmers to improve their bottom line while increasing the sustainability of their operations.
- Sector
- Materials and Resources
- HQ
- Cambridge, MA, United States
- Founded
- 2020
- Employees
- 16
- Website
- robigo.bio/
- Ownership
- Privately Held (backing)
Robigo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Robigo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Robigo in its N-PORT filings yet. We sweep new filings monthly.